PlenOptika brings cutting-edge optical technology to eye care professionals and healthcare providers worldwide. Our flagship product, QuickSee™, is the world’s most accurate handheld autorefractor. Combining an open and binocular view, wavefront aberrometry, and continuous measurements in a field-durable hand-held format, QuickSee enables clinically accurate autorefraction anywhere.
PlenOptika technology combines excellent engineering, creative innovation, and a steadfast focus on human-centered design to meet the global challenge of low vision. Our core platform technology, the patented PlenOptika Wavefront Refraction Engine, offers eye care professionals and healthcare providers an unprecedented combination of clinical power and usability suited equally for the modern clinic, optical retail store, home visit, and global health mission. QuickSee has measured more than 3 million people to date in 45 countries.
Eye health and the United Nations Sustainable Development Goals
PlenOptika traces its origin to inventions meant to solve the global challenge of uncorrected refractive error. Today, our mission aligns with the UN Sustainable Development Goals at many points:
The PlenOptika founders invented QuickSee to respond to a key bottleneck in vision care: fast, accurate refraction at scale. Photo courtesy Aravind Eye Care System
Discovering the global burden of low vision, PlenOptika’s founders determined to design a solution that could provide better eye care for everyone, regardless of their circumstances and access to health care. The company has strong research and development relationships with institutions and agencies around the world, including the Aravind Eye Hospital (India), the Regional Government of Madrid (Spain), the National Institutes of Health, and the Massachusetts Institute of Technology—where our technology was invented and the first prototypes were designed. Based in Boston, Massachusetts, we have offices in Madrid and Singapore, and we’re proud to count among our board and advisors some of the world’s leading experts in optical science, clinical eye care, and business strategy.
Peer-reviewed research publications confirm our technology’s accuracy. Our research has been published in BMJ Open Ophthalmology, Optometry and Vision Science, Investigative Ophthalmology & Visual Science, and Annual Review of Biomedical Engineering.
Highlights from our research show there was no statistically significant difference in the preferences for eyeglasses derived from subjective refraction versus those from QuickSee autorefraction, and that QuickSee provides measurements that agree more closely with subjective refraction than other handheld autorefractors.
PlenOptika and QuickSee have been recognized internationally by Essilor, ASME, Indo-US Science Technology Forum Endowment Fund, the Hult Prize, Beazley Designs of the Year, and MassChallenge and many others. We have been covered by Bloomberg Businessweek, MIT News, Vision Monday, FastCompany, the Boston Globe and other news outlets.
Initial funding for the Quicksee technology was provided by the Ministry of Education of the Madrid Region, Spain, through the Madrid-MIT M+Visión Consortium, managed by the Madri+d Foundation and MIT.
Photonics Center
© 2022 PlenOptika. All rights Reserved.
